有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | 2-[[5-(3,5-dimethylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-[(3R)-1,1-dioxothiolan-3-yl]-N-methylacetamide | —— | C17H21N3O4S2 |
|
—— | (2S)-2-[[5-(3,5-dimethylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-1-(4-ethylpiperazin-1-yl)propan-1-one | —— | C19H26N4O2S |
|
—— | 1-[2,5-dimethyl-1-[[(2R)-oxolan-2-yl]methyl]pyrrol-3-yl]-2-[[5-(3,5-dimethylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]ethanone | —— | C23H27N3O3S |
|
—— | 1-[2,5-dimethyl-1-[[(2S)-oxolan-2-yl]methyl]pyrrol-3-yl]-2-[[5-(3,5-dimethylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]ethanone | —— | C23H27N3O3S |
|
—— | 2-[[5-(3,5-dimethylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-[2-(2,4-dioxo-1,3-thiazolidin-3-yl)ethyl]acetamide | —— | C17H18N4O4S2 |
|
—— | N-butyl-2-[[5-(3,5-dimethylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]acetamide | —— | C16H21N3O2S |
|
—— | N,N-bis(2-cyanoethyl)-2-[[5-(3,5-dimethylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]acetamide | —— | C18H19N5O2S |
|
—— | 2-(4-Chlorophenyl)-5-[[5-(3,5-dimethylphenyl)-1,3,4-oxadiazol-2-yl]sulfanylmethyl]-1,3,4-oxadiazole | —— | C19H15ClN4O2S |
|
—— | 1-(5-Chlorothiophen-2-yl)-2-[[5-(3,5-dimethylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]ethanone | —— | C16H13ClN2O2S2 |
|
—— | ethyl 5-[2-[[5-(3,5-dimethylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]acetyl]-2,4-dimethyl-1H-pyrrole-3-carboxylate | —— | C21H23N3O4S |
|
—— | 1-(4-Acetylpiperazin-1-yl)-2-[[5-(3,5-dimethylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]ethanone | —— | C18H22N4O3S |
|
—— | 2-[[5-(3,5-dimethylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N,N-dimethylacetamide | —— | C14H17N3O2S |
|
—— | 2-[[5-(3,5-dimethylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-(3-phenylpropyl)acetamide | —— | C21H23N3O2S |
|
—— | 2-[[5-(3,5-dimethylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-[[(2R)-oxolan-2-yl]methyl]acetamide | —— | C17H21N3O3S |
|
—— | 1-(5-Bromothiophen-2-yl)-2-[[5-(3,5-dimethylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]ethanone | —— | C16H13BrN2O2S2 |
|
—— | N-[(2-chlorophenyl)methyl]-2-[[5-(3,5-dimethylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]acetamide | —— | C19H18ClN3O2S |
|
—— | N-benzyl-2-[[5-(3,5-dimethylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-methylacetamide | —— | C20H21N3O2S |
|
—— | 2-[[5-(3,5-dimethylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-[[(2S)-oxolan-2-yl]methyl]acetamide | —— | C17H21N3O3S |
|
—— | methyl (2S)-2-[[5-(3,5-dimethylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]propanoate | —— | C14H16N2O3S |
|
—— | 2-[(2-Chlorophenyl)methylsulfanyl]-5-(3,5-dimethylphenyl)-1,3,4-oxadiazole | —— | C17H15ClN2OS |
|
—— | methyl (2R)-2-[[5-(3,5-dimethylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]propanoate | —— | C14H16N2O3S |
|
—— | N-[(2-chlorophenyl)methyl]-6-[(3-methylphenyl)methylsulfanyl]pyrimidin-4-amine | —— | C19H18ClN3S |
|
—— | 2-[(3-Methylphenyl)methylsulfanyl]-5-[(5-methylpyrazol-1-yl)methyl]-1,3,4-oxadiazole | —— | C15H16N4OS |
|
—— | [(1S)-1-[4-benzyl-5-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]sulfanyl-1,2,4-triazol-3-yl]propyl]-dimethylazanium | —— | C18H25F3N5OS+ |
|
—— | 2-(3,5-Dimethylpyrazol-1-yl)-3-[(3-methylphenyl)methylsulfanyl]pyrazine | —— | C17H18N4S |
|
—— | 4-[(3R,5R)-3,5-dimethylpiperidin-1-yl]-2-[(3-methylphenyl)methylsulfanyl]pyrimidine | —— | C19H25N3S |
|
—— | 2-(3-Chlorophenyl)-4-methyl-6-[(3-methylphenyl)methylsulfanyl]pyrimidine | —— | C19H17ClN2S |
|
—— | 2-[(3-Methylphenyl)methylsulfanyl]-3-piperidin-1-ylpyrazine | —— | C17H21N3S |
|
—— | 2-Methyl-4-[(3-methylphenyl)methylsulfanyl]-6-pyridin-2-ylpyrimidine | —— | C18H17N3S |
|
—— | 2-(4-Chlorophenyl)-4-methyl-6-[(3-methylphenyl)methylsulfanyl]pyrimidine | —— | C19H17ClN2S |
|
—— | 4-Methyl-2-(4-methylphenyl)-6-[(3-methylphenyl)methylsulfanyl]pyrimidine | —— | C20H20N2S |
|
—— | 3-[(3-Methylphenyl)methylsulfanyl]-5-(2-methylsulfanylethyl)-1,2,4-triazol-4-amine | —— | C13H18N4S2 |
|
—— | 4-[7-[(3-Methylphenyl)methylsulfanyl]-[1,3]thiazolo[4,5-d]pyrimidin-2-yl]morpholine | —— | C17H18N4OS2 |
|
—— | 4-[(3R,5S)-3,5-dimethylpiperidin-1-yl]-2-[(3-methylphenyl)methylsulfanyl]pyrimidine | —— | C19H25N3S |
|
—— | 2-[(4-Bromophenyl)methylsulfanyl]-5-(3,5-dimethylphenyl)-1,3,4-oxadiazole | —— | C17H15BrN2OS |
|
—— | 4-[(3S,5S)-3,5-dimethylpiperidin-1-yl]-2-[(3-methylphenyl)methylsulfanyl]pyrimidine | —— | C19H25N3S |
|
—— | 4-[(3-methylphenyl)methylsulfanyl]-6-[(3S)-3-methylpiperidin-1-yl]pyrimidine | —— | C18H23N3S |
|
—— | 2-[(3-Methylphenyl)methylsulfanyl]-3-pyrazol-1-ylpyrazine | —— | C15H14N4S |
|
—— | 2-[[4-amino-5-(2-methylsulfanylethyl)-1,2,4-triazol-3-yl]sulfanyl]-N-cyclohexylacetamide | —— | C13H23N5OS2 |
|
—— | 3-[(3,4-Difluorophenyl)methylsulfanyl]-5-(2-methylsulfanylethyl)-1,2,4-triazol-4-amine | —— | C12H14F2N4S2 |
|
—— | 4-(3,5-Dimethylpyrazol-1-yl)-6-[(3-methylphenyl)methylsulfanyl]pyrimidine | —— | C17H18N4S |
|
—— | 2-[[4-benzyl-5-[(1R)-1-(dimethylamino)propyl]-1,2,4-triazol-3-yl]sulfanyl]-N-(2,2,2-trifluoroethyl)acetamide | —— | C18H24F3N5OS |
|
—— | 4-[(3S,5S)-3,5-dimethylpiperidin-1-yl]-6-[(3-methylphenyl)methylsulfanyl]pyrimidine | —— | C19H25N3S |
|
—— | 2-[[4-amino-5-(2-methylsulfanylethyl)-1,2,4-triazol-3-yl]sulfanyl]-N-[(4-methylphenyl)methyl]acetamide | —— | C15H21N5OS2 |
|
—— | 3-[(2,5-Difluorophenyl)methylsulfanyl]-5-(2-methylsulfanylethyl)-1,2,4-triazol-4-amine | —— | C12H14F2N4S2 |
|
—— | 3-Methyl-1-[6-[(3-methylphenyl)methylsulfanyl]pyrimidin-4-yl]-4,5,6,7-tetrahydroindazole | —— | C20H22N4S |
|
—— | 4-[(3R,5S)-3,5-dimethylpiperidin-1-yl]-6-[(3-methylphenyl)methylsulfanyl]pyrimidine | —— | C19H25N3S |
|
—— | 1-[(3-Methylphenyl)methyl]-4-methylsulfanyl-6-oxopyrimidine-5-carbonitrile | —— | C14H13N3OS |
|
—— | 4-[(3-Methylphenyl)methylsulfanyl]-6-(4-methylpiperidin-1-yl)pyrimidine | —— | C18H23N3S |
|
—— | 2-[[4-amino-5-(2-methylsulfanylethyl)-1,2,4-triazol-3-yl]sulfanyl]-N-[(4-fluorophenyl)methyl]acetamide | —— | C14H18FN5OS2 |
|